| Product Code: ETC9962993 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Common Cold Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Common Cold Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Common Cold Market - Industry Life Cycle |
3.4 United States (US) Common Cold Market - Porter's Five Forces |
3.5 United States (US) Common Cold Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 United States (US) Common Cold Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 United States (US) Common Cold Market Revenues & Volume Share, By Medication Class, 2021 & 2031F |
4 United States (US) Common Cold Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of preventive healthcare measures |
4.2.2 Growing demand for natural and herbal remedies for common cold |
4.2.3 Rising disposable income leading to higher spending on healthcare products |
4.3 Market Restraints |
4.3.1 Seasonality of common cold leading to fluctuating demand for related products |
4.3.2 Competition from alternative treatments and home remedies |
4.3.3 Side effects associated with certain over-the-counter cold medications |
5 United States (US) Common Cold Market Trends |
6 United States (US) Common Cold Market, By Types |
6.1 United States (US) Common Cold Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Common Cold Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 United States (US) Common Cold Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.1.4 United States (US) Common Cold Market Revenues & Volume, By Excision, 2021- 2031F |
6.2 United States (US) Common Cold Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Common Cold Market Revenues & Volume, By Imiquimod, 2021- 2031F |
6.2.3 United States (US) Common Cold Market Revenues & Volume, By Silver Nitrate, 2021- 2031F |
6.2.4 United States (US) Common Cold Market Revenues & Volume, By Glutaraldehyde, 2021- 2031F |
6.2.5 United States (US) Common Cold Market Revenues & Volume, By Salicylic Acid, 2021- 2031F |
6.2.6 United States (US) Common Cold Market Revenues & Volume, By Formaldehydel, 2021- 2031F |
6.2.7 United States (US) Common Cold Market Revenues & Volume, By Aminolevulinic Acid, 2021- 2031F |
6.3 United States (US) Common Cold Market, By Medication Class |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Common Cold Market Revenues & Volume, By Topical Retinoids, 2021- 2031F |
6.3.3 United States (US) Common Cold Market Revenues & Volume, By Oral Retinoids, 2021- 2031F |
7 United States (US) Common Cold Market Import-Export Trade Statistics |
7.1 United States (US) Common Cold Market Export to Major Countries |
7.2 United States (US) Common Cold Market Imports from Major Countries |
8 United States (US) Common Cold Market Key Performance Indicators |
8.1 Number of doctor visits for common cold symptoms |
8.2 Percentage of households purchasing over-the-counter cold remedies |
8.3 Consumer satisfaction with common cold products |
9 United States (US) Common Cold Market - Opportunity Assessment |
9.1 United States (US) Common Cold Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 United States (US) Common Cold Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 United States (US) Common Cold Market Opportunity Assessment, By Medication Class, 2021 & 2031F |
10 United States (US) Common Cold Market - Competitive Landscape |
10.1 United States (US) Common Cold Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Common Cold Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here